指南与共识腹部技术与安全US

AFSUMB关于使用Sonazoid进行对比增强超声临床实践的共识声明与推荐

The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
指南 / 共识 · Ultrasonography · 2020-04-27

亚洲超声医学与生物学联合会发布关于Sonazoid对比增强超声临床实践的共识声明与推荐,旨在为亚洲患者肝脏及胰胆应用建立标准方案。此前指南主要针对其他造影剂,Sonazoid临床经验仅限于日本和韩国,本共识提供使用与给药的一般性建议以改善患者管理。

要点

  • Sonazoid对比增强超声的共识推荐覆盖肝脏及胰胆应用,面向亚洲患者人群。
  • 原文指出既往无主要针对Sonazoid的指南,临床经验仅限日本和韩国。
  • 本共识旨在建立Sonazoid使用与给药的标准方案以改善患者管理。

临床应用与阅片要点

  • 原文旨在为亚洲患者肝脏及胰胆应用中的Sonazoid使用与给药建立标准方案。

局限性

  • 原文指出此前无主要针对Sonazoid的指南,原因是临床经验仅限于日本和韩国。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The first edition of the guidelines for the use of ultrasound contrast agents was published in 2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some nonliver applications. The third edition of the contrast-enhanced ultrasound (CEUS) guidelines was the joint World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) venture in conjunction with other regional US societies such as Asian Federation of Societies for Ultrasound in Medicine and Biology, resulting in a simultaneous duplicate on liver CEUS in the official journals of both WFUMB and EFSUMB in 2013. However, no guidelines were described mainly for Sonazoid due to limited clinical experience only in Japan and Korea. The new proposed consensus statements and recommendations provide general advice on the use of Sonazoid and are intended to create standard protocols for the use and administration of Sonazoid in hepatic and pancreatobiliary applications in Asian patients and to improve patient management.

来源:Ultrasonography,查看原文。版权归原作者所有。

引用

  1. Lee JY, Minami Y, Choi BI, et al. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography. 2020. PMID: 32447876. doi:10.14366/usg.20057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。